JNJ

JOHNSON & JOHNSON

JNJ·478160104·US·Common Stock·Healthcare - Drug Manufacturers - General-13D/G

JNJ institutional ownership changes in Q2 2026: 186 institutions opened or added positions, 199 trimmed or exited. JNJ (JOHNSON & JOHNSON) is held by 389 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($53.9B), VANGUARD CAPITAL MANAGEMENT LLC ($39.9B), STATE STREET CORP ($34B). Net institutional sentiment: Mixed.

389
Holders
(45 Elite)
$415.6B
Total Value
48% (385)
Consensus
186 buying - 199 selling
13F: Insider & Congress: Updated regularly
JNJ

Smart Money Verdict

View all
Loading verdict
Held by 389 funds
45 elite

Who's Trading

Source dates: Price Oct 29, 2026 · Insiders Sep 4, 2026 · Activists May 1, 2026 · Congress Oct 5, 2026

CongressLloyd DoggettLloyd DoggettBuy $1,001 - $15,000Sep 8, 2026
InsiderSTSchmid TimothyExercise 23K shSep 2, 2026
InsiderSTSchmid TimothySell $3.0MSep 2, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
212.1M(-0.6%)$53.9B0.8%+73.72%
0
Increased
157.2M(+0.4%)$39.9B0.9%+12.05%
45
Increased
133.8M(+0.2%)$34B1.0%+143.15%
50
Increased
64.4M(+1.4%)$16.3B0.7%+12.00%
45
Decreased
58.3M(-7.6%)$15.1B0.8%+68.11%
0
Decreased
59.1M(-0.1%)$15B0.8%+114.96%
0
Increased
44.8M(+0.2%)$11.4B0.6%+92.27%
45
Unchanged
31.6M$8B5.5%+159.78%
0
Decreased
28.8M(-1.8%)$7.3B0.9%+127.33%
0
Decreased
23.4M(-8.2%)$6B0.4%+71.06%
0
Increased
23M(+39.5%)$5.8B0.6%+35.90%
59
Decreased
22.6M(-8.8%)$5.7B0.2%+56.22%
0
Increased
22.6M(+12.5%)$5.7B1.0%+97.04%
51
Decreased
21.7M(-0.6%)$5.5B0.9%+118.66%
0
Increased
19.7M(+9.2%)$5B0.4%+51.13%
42
Decreased
19.3M(-0.3%)$4.9B1.0%+118.23%
0
Decreased
19.1M(-0.3%)$4.9B0.6%+129.55%
0
Decreased
18.4M(-6.2%)$4.7B0.9%+82.64%
0
Increased
17.4M(+2.6%)$4.4B0.7%+129.84%
46
Increased
15.7M(+4.2%)$4B0.3%+81.38%
40

Showing 1-20 of 397

1 / 20
JNJJNJJOHNSON & JOHNSON

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used